CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...